Getting Prescribed as a Young Adult: BMI, Age, and Eligibility Rules Explained
FDA eligibility criteria don't restrict by age, but prescriber reluctance and borderline BMI create real friction for younger patients. The eligibility framework, comorbidity documentation, and off-label options.
Young adults (18–35) trying to get a GLP-1 prescription encounter specific eligibility questions: BMI requirements, whether being young is a factor, what to do when you're below the BMI cutoff but have metabolic concerns. Here's how eligibility actually works for younger patients.
The FDA-approved eligibility criteria (unchanged for age)
FDA approval for Wegovy and Zepbound applies to adults with: BMI ≥30 kg/m² (obesity), OR BMI ≥27 with at least one weight-related comorbidity. Age is not a criterion — there's no minimum age restriction for adult GLP-1 obesity prescribing beyond the general adult threshold (18+). Adolescent prescribing (12–17) is covered under separate pediatric approvals.
Some prescribers are reluctant to prescribe GLP-1s to patients in their 20s without significant metabolic disease. This is clinical judgment, not a regulatory requirement — the BMI criteria are met or not regardless of age. If one provider declines, another may prescribe based on the same clinical picture.
When BMI is borderline (27-30)
If your BMI is 27-30, you need a qualifying comorbidity. These are the most commonly documented:
- Hypertension (including pre-hypertension in some clinical judgment)
- Elevated fasting glucose or insulin resistance / pre-diabetes (A1C 5.7-6.4%)
- Dyslipidemia (high LDL, low HDL, high triglycerides)
- Sleep apnea (diagnosed or with clinical suspicion)
- Polycystic ovary syndrome (PCOS) with documented androgenic or metabolic features
- Non-alcoholic fatty liver disease (MASLD/MAFLD)
A lab panel establishing any of these — particularly A1C showing pre-diabetes — creates the comorbidity documentation needed for prescribing at BMI 27-30.
Off-label prescribing for lower BMI
For patients below BMI 27, off-label prescribing exists but is less common through mainstream telehealth platforms. Platforms with a longevity or metabolic health framing (Ageless, for example) may be more willing to evaluate the full metabolic picture rather than strictly applying BMI cutoffs.
Verified telehealth providers
BMI and eligibility evaluation. Licensed providers who can document comorbidities.
Paid link Get started →Metabolic health framing — evaluates full picture beyond BMI threshold.
Paid link Get started →